financetom
Business
financetom
/
Business
/
MannKind Says 6-Month Results of Phase 3 Study for Inhaled Insulin Afrezza Meet Primary Endpoint
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MannKind Says 6-Month Results of Phase 3 Study for Inhaled Insulin Afrezza Meet Primary Endpoint
Dec 16, 2024 5:33 AM

08:00 AM EST, 12/16/2024 (MT Newswires) -- MannKind ( MNKD ) said Monday the six-month results of its phase 3 INHALE-1 study showed inhaled insulin Afrezza in children and adolescents aged four to 17 established the non-inferiority of Afrezza to multiple daily injections, which was the primary endpoint of the study.

The study compared Afrezza with multiple daily injections of rapid-acting insulin analogs, alongside basal insulin, over 26 weeks. Results from the modified intent-to-treat analysis confirmed that Afrezza met the non-inferiority threshold in HbA1c change compared with multiple daily injections.

No significant differences in lung function or safety, including hypoglycemia, were observed between the groups over the 26-week-period.

MannKind ( MNKD ) said it plans to meet with the FDA to discuss filing a supplemental new drug application in H1 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Opendoor Stock Is Soaring Monday: What's Going On?
Opendoor Stock Is Soaring Monday: What's Going On?
Jul 21, 2025
Shares of Opendoor Technologies Inc. ( OPEN ) are trading higher Monday as the stock continues to ride momentum fueled by retail investor interest and broader sector movement. What To Know: The rally in Opendoor ( OPEN ) stock comes despite an uncertain financial outlook and macroeconomic headwinds facing the housing market. The momentum appears to be fueled by retail...
Stellantis Expects Greater Tariffs Impact in Second Half as Weak Shipments Partly Drive First-Half Loss Guidance
Stellantis Expects Greater Tariffs Impact in Second Half as Weak Shipments Partly Drive First-Half Loss Guidance
Jul 21, 2025
03:09 PM EDT, 07/21/2025 (MT Newswires) -- Stellantis ( STLA ) said Monday that US tariffs will likely cost it more in the second half than they did in the first, as weak shipments were among factors that drove the automaker's preliminary first-half loss guidance. The parent of brands including Jeep and Dodge expects to report a first-half net loss...
Rogers Communications Prices Tender Offers for Canadian Dollar Debt Securities
Rogers Communications Prices Tender Offers for Canadian Dollar Debt Securities
Jul 21, 2025
03:14 PM EDT, 07/21/2025 (MT Newswires) -- Rogers Communications ( RCIAF ) on Monday priced its tender offers for its Canadian dollar debt securities. The total consideration for 4.25% senior notes due 2049 was 872.77 Canadian dollars ($637.74) per CA$1,000 principal amount of such series; 2.90% senior notes due 2030 was CA$956.74; 3.30% senior notes due 2029 was CA$981.51; and...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved